Receptors and Channels Possibly Mediating the Effects of Phytocannabinoids on Seizures and Epilepsy
Epilepsy contributes to approximately 1% of the global disease burden. By affecting especially young children as well as older persons of all social and racial variety, epilepsy is a present disorder worldwide. Currently, only 65% of epileptic patients can be successfully treated with antiepileptic...
Main Authors: | Lara Senn, Giuseppe Cannazza, Giuseppe Biagini |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/13/8/174 |
Similar Items
-
Phytocannabinoids Reduce Seizures in Larval Zebrafish and Affect Endocannabinoid Gene Expression
by: Roshni Kollipara, et al.
Published: (2023-09-01) -
Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence
by: Cecilia Zavala-Tecuapetla, et al.
Published: (2022-12-01) -
Phytocannabinoid-rich galenic preparations for topical administration: extraction and stability testing
by: Dominika Kaczorová, et al.
Published: (2023-08-01) -
Early and Late Postoperative Seizures in Meningioma Patients and Prediction by a Recent Scoring System
by: Peter Baumgarten, et al.
Published: (2021-01-01) -
Virus-Induced Epilepsy vs. Epilepsy Patients Acquiring Viral Infection: Unravelling the Complex Relationship for Precision Treatment
by: Bárbara Costa, et al.
Published: (2024-03-01)